Allogenic mesenchymal stem cells as a treatment for equine degenerative joint disease: a pilot study S Broeckx, M Suls, C Beerts, A Vandenberghe, B Seys, K Wuertz-Kozak, ... Current stem cell research & therapy 9 (6), 497-503, 2014 | 83 | 2014 |
Tenogenically induced allogeneic peripheral blood mesenchymal stem cells in allogeneic platelet-rich plasma: 2-year follow-up after tendon or ligament treatment in horses C Beerts, M Suls, SY Broeckx, B Seys, A Vandenberghe, J Declercq, ... Frontiers in Veterinary Science 4, 158, 2017 | 53 | 2017 |
Tenogenically induced allogeneic mesenchymal stem cells for the treatment of proximal suspensory ligament desmitis in a horse A Vandenberghe, SY Broeckx, C Beerts, B Seys, M Zimmerman, ... Frontiers in Veterinary Science 2, 49, 2015 | 42 | 2015 |
A feasibility study on the use of equine chondrogenic induced mesenchymal stem cells as a treatment for natural occurring osteoarthritis in dogs R Daems, L Van Hecke, I Schwarzkopf, E Depuydt, SY Broeckx, M David, ... Stem Cells International 2019 (1), 4587594, 2019 | 29 | 2019 |
The evaluation of equine allogeneic tenogenic primed mesenchymal stem cells in a surgically induced superficial digital flexor tendon lesion model E Depuydt, SY Broeckx, L Van Hecke, K Chiers, L Van Brantegem, ... Frontiers in veterinary science 8, 641441, 2021 | 22 | 2021 |
Desmitis of the accessory ligament of the equine deep digital flexor tendon: a regenerative approach C Beerts, C Seifert, M Zimmerman, E Felix, M Suls, T Mariën, S Broeckx, ... J Tissue Sci Eng 4 (1), 1-7, 2013 | 20 | 2013 |
Repeated intra-articular administration of equine allogeneic peripheral blood-derived mesenchymal stem cells does not induce a cellular and humoral immune response in horses L Van Hecke, C Magri, L Duchateau, C Beerts, F Geburek, M Suls, ... Veterinary immunology and immunopathology 239, 110306, 2021 | 18 | 2021 |
Safety and immunomodulatory properties of equine peripheral blood-derived mesenchymal stem cells in healthy cats Y Debosschere, E Depuydt, G Pauwelyn, C Beerts, L Van Hecke, ... Veterinary Immunology and Immunopathology 227, 110083, 2020 | 13 | 2020 |
Scintigraphic tracking of 99mTechnetium-labelled equine peripheral blood-derived mesenchymal stem cells after intravenous, intramuscular, and subcutaneous … C Beerts, C Brondeel, G Pauwelyn, E Depuydt, L Tack, L Duchateau, Y Xu, ... Stem Cell Research & Therapy 12, 1-11, 2021 | 9 | 2021 |
Equine allogeneic tenogenic primed mesenchymal stem cells: a clinical field study in horses suffering from naturally occurring superficial digital flexor tendon and suspensory … S Carlier, E Depuydt, M Suls, C Bocqué, J Thys, A Vandenberghe, ... Equine Veterinary Journal 56 (5), 924-935, 2024 | 4 | 2024 |
Homing of radiolabelled xenogeneic equine peripheral blood-derived MSCs towards a joint lesion in a dog C Beerts, G Pauwelyn, E Depuydt, Y Xu, JH Saunders, K Peremans, ... Frontiers in Veterinary Science 9, 1035175, 2022 | 3 | 2022 |
Mesenchymal stem cells for use in the treatment of chronic gingivostomatitis J Spaas, C Beerts, T Liesa US Patent App. 17/857,754, 2023 | 1 | 2023 |
Mesenchymal stem cells for use in the treatment of chronic kidney disease J Spaas, C Beerts, E Depuydt US Patent App. 17/857,804, 2023 | 1 | 2023 |
Low-dose xenogeneic mesenchymal stem cells target canine osteoarthritis through systemic immunomodulation and homing C Beerts, SY Broeckx, E Depuydt, L Tack, L Van Hecke, K Chiers, ... Arthritis Research & Therapy 25 (1), 190, 2023 | | 2023 |
Mesenchymal stem cells for use in the treatment of osteoarthritis in animals J Spaas, S Broeckx, G Pauwelyn, C Beerts US Patent App. 17/857,393, 2023 | | 2023 |
Cell Composition Comprising Radiolabled Mesenchymal Stem Cells, Use Thereof and Method for Preparing Radiolabeled Mesenchymal Stem Cells C Beerts, J Spaas, E Depuydt US Patent App. 17/763,078, 2022 | | 2022 |
Xenogeneic use of equine peripheral blood-derived mesenchymal stem cells for treatment of osteoarthritis in dogs C Beerts Ghent University, 2022 | | 2022 |
Research Article A Feasibility Study on the Use of Equine Chondrogenic Induced Mesenchymal Stem Cells as a Treatment for Natural Occurring Osteoarthritis in Dogs R Daems, L Van Hecke, I Schwarzkopf, E Depuydt, SY Broeckx, M David, ... | | 2019 |
Die erste arzneimittelrechtlich zugelassene Zelltherapie zur Gelenkbehandlung beim Pferd JH Spaas, C Beerts, SY Broeckx Leipziger Blaue Hefte, 159, 0 | | |
Tenogenic primed mesenchymal stem cells for the treatment of tendon lesions in horses C Beerts, E Depuydt, S Carlier, SY Broeckx, JH Spaas Leipziger Blaue Hefte, 59, 0 | | |